Biodegradable PLGA Based Nanoparticles for Sustained Regional Lymphatic Drug Delivery

Overview

Journal J Pharm Sci

Publisher Elsevier

Specialties Pharmacology
Pharmacy

Date 2009 Nov 11

PMID 19902520

Citations 67

Authors

Deepa A Rao

M Laird Forrest

Adam W G Alani

Glen S Kwon

Joseph R Robinson

Affiliations

Soon will be listed here.

Abstract

The purpose of this work is to evaluate biodegradable drug carriers with defined size, hydrophobicity, and surface charge density for preferential lymphatic uptake and retention for sustained regional drug delivery. PLGA-PMA:PLA-PEG (PP) nanoparticles of defined size and relative hydrophobicity were prepared by nanoprecipitation method. These were compared with PS particles of similar sizes and higher hydrophobicity. PLGA-PMA:PLGA-COOH (PC) particles at 80:20, 50:50, and 20:80 ratios were prepared by nanoprecipitation for the charge study. Particle size and zeta potential were characterized by dynamic light scattering and laser doppler anemometry, respectively. Particles were administered in vivo to rats subcutaneously. Systemic and lymph node uptake was evaluated by marker recovery. Lymphatic uptake and node retention of PP nanoparticles was shown to be inversely related to size. Lymphatic uptake and node retention of PP particles, as compared to PS particles, was shown to be inversely related to hydrophobicity. Lastly, lymphatic uptake and node retention of PC nanoparticles were directly related to the anionic charge on the particles. In vivo lymphatic uptake and retention in a rat model indicates that the 50 nm PP particles are ideal for sustained regional delivery into the lymphatics for prevention/treatment of oligometastases.

Citing Articles

Progress in Nanotechnology for Treating Ocular Surface Chemical Injuries: Reflecting on Advances in Ophthalmology.

Qi Q, Su D, Zhuang S, Yao S, Heindl L, Fan X Adv Sci (Weinh). 2025; 12(6):e2407340.

PMID: 39755928 PMC: 11809354. DOI: 10.1002/advs.202407340.

Tailoring biomaterials for vaccine delivery.

Zhuo Y, Zeng H, Su C, Lv Q, Cheng T, Lei L J Nanobiotechnology. 2024; 22(1):480.

PMID: 39135073 PMC: 11321069. DOI: 10.1186/s12951-024-02758-0.

Albumin-seeking dyes with adjustable assemblies enable programmable imaging windows and targeting tumor imaging.

Du Y, Xu J, Han T, Jiang Z, Zhang Y, Li J Theranostics. 2024; 14(7):2675-2686.

PMID: 38773981 PMC: 11103493. DOI: 10.7150/thno.92991.

Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes.

Babalola K, Arora M, Ganugula R, Agarwal S, Mohan C, Kumar M Pharmacol Rev. 2024; 76(2):228-250.

PMID: 38351070 PMC: 10877736. DOI: 10.1124/pharmrev.123.000938.

Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines.

Ou B, Baillet J, Picece V, Gale E, Powell A, Saouaf O ACS Nano. 2024; 18(4):3214-3233.

PMID: 38215338 PMC: 10832347. DOI: 10.1021/acsnano.3c09700.

References

Hawley A, Illum L, Davis S . Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers. FEBS Lett. 1997; 400(3):319-23. DOI: 10.1016/s0014-5793(96)01408-1. View

Narrainen A, Hutchings L, Ansari I, Clarke N, Thompson R . Novel multi end-functionalised polymers. Additives to modify polymer properties at surfaces and interfaces. Soft Matter. 2020; 2(2):126-128. DOI: 10.1039/b516439g. View

Weissenboeck A, Bogner E, Wirth M, Gabor F . Binding and uptake of wheat germ agglutinin-grafted PLGA-nanospheres by caco-2 monolayers. Pharm Res. 2004; 21(10):1917-23. DOI: 10.1023/b:pham.0000045247.09724.26. View

Kiss E, Bertoti I, Vargha-Butler E . XPS and wettability characterization of modified poly(lactic acid) and poly(lactic/glycolic acid) films. J Colloid Interface Sci. 2005; 245(1):91-8. DOI: 10.1006/jcis.2001.7954. View

van Oosterhout M, Willigers H, Reneman R, Prinzen F . Fluorescent microspheres to measure organ perfusion: validation of a simplified sample processing technique. Am J Physiol. 1995; 269(2 Pt 2):H725-33. DOI: 10.1152/ajpheart.1995.269.2.H725. View

Lekkerkerker A, van Kooyk Y, Geijtenbeek T . Viral piracy: HIV-1 targets dendritic cells for transmission. Curr HIV Res. 2006; 4(2):169-76. DOI: 10.2174/157016206776055020. View

Hawley A, Illum L, Davis S . Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res. 1997; 14(5):657-61. DOI: 10.1023/a:1012117531448. View

Supersaxo A, Hein W, Steffen H . Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration. Pharm Res. 1990; 7(2):167-9. DOI: 10.1023/a:1015880819328. View

Takakura Y, Matsumoto S, Hashida M, Sezaki H . Enhanced lymphatic delivery of mitomycin C conjugated with dextran. Cancer Res. 1984; 44(6):2505-10. View

10.

Horisawa E, Kubota K, Tuboi I, Sato K, Yamamoto H, Takeuchi H . Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm Res. 2002; 19(2):132-9. DOI: 10.1023/a:1014260513728. View

11.

Oussoren C, Storm G . Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev. 2001; 50(1-2):143-56. DOI: 10.1016/s0169-409x(01)00154-5. View

12.

Oussoren C, Storm G . Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influence of surface modification with poly(ethyleneglycol). Pharm Res. 1997; 14(10):1479-84. DOI: 10.1023/a:1012145410859. View

13.

Patel H, Tuzel N, RYMAN B . Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen. Biochim Biophys Acta. 1983; 761(2):142-51. DOI: 10.1016/0304-4165(83)90223-4. View

14.

Dunne M, Corrigan I, Ramtoola Z . Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials. 2000; 21(16):1659-68. DOI: 10.1016/s0142-9612(00)00040-5. View

15.

Panyam J, Dali M, Sahoo S, Ma W, Chakravarthi S, Amidon G . Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. J Control Release. 2003; 92(1-2):173-87. DOI: 10.1016/s0168-3659(03)00328-6. View

16.

Yin F, Das S, Kirkpatrick J, Oldham M, Wang Z, Zhou S . Physics and imaging for targeting of oligometastases. Semin Radiat Oncol. 2006; 16(2):85-101. DOI: 10.1016/j.semradonc.2005.12.004. View

17.

Sallustio G, Giangregorio C, Cannas L, Vricella D, Celi G, Rinaldi P . Lymphatic system: morphofunctional considerations. Rays. 2001; 25(4):419-27. View

18.

Querzoli P, Pedriali M, Rinaldi R, Lombardi A, Biganzoli E, Boracchi P . Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res. 2006; 12(22):6696-701. DOI: 10.1158/1078-0432.CCR-06-0569. View

19.

Charman S, Segrave A, Edwards G, Porter C . Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection. J Pharm Sci. 2000; 89(2):168-77. DOI: 10.1002/(SICI)1520-6017(200002)89:2<168::AID-JPS4>3.0.CO;2-Q. View

20.

Oussoren C, Zuidema J, Crommelin D, Storm G . Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. Biochim Biophys Acta. 1997; 1328(2):261-72. DOI: 10.1016/s0005-2736(97)00122-3. View